Gavin Giovannoni, MD

Articles

Anti-CD20 Agents for Relapsing MS

July 24, 2021

A panel of experts discuss the use of anti-CD20 monoclonal antibodies in relapsing multiple sclerosis including summaries of the phase III ORATORIO and ASCLEPIOS trials, for ocrelizumab and ofatumumab, respectively.